Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2010-07-22 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DREMIL-LAFAGE (31280), Haute-Garonne
PHARMACIE CAMPOURCY : revenue, balance sheet and financial ratios
PHARMACIE CAMPOURCY is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DREMIL-LAFAGE (31280),
this company of category PME
shows in 2022 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CAMPOURCY (SIREN 524930278)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 634 309 €
3 106 925 €
2 889 823 €
2 605 736 €
2 484 324 €
N/C
1 917 503 €
Net income
68 466 €
94 463 €
79 711 €
-27 721 €
63 923 €
87 364 €
74 464 €
68 079 €
63 661 €
EBITDA
N/C
N/C
155 189 €
54 848 €
134 196 €
160 517 €
177 343 €
N/C
131 362 €
Net margin
N/C
N/C
3.0%
-0.9%
2.2%
3.4%
3.0%
N/C
3.3%
Revenue and income statement
In 2024, PHARMACIE CAMPOURCY generates positive net income of 68 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 64 k€ -> 68 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
68 466 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
70.107%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.394%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
231.734
190.818
152.329
117.249
97.413
109.394
98.828
83.367
70.107
Financial autonomy
25.961
28.853
32.367
36.621
38.665
38.075
38.551
41.035
47.394
Repayment capacity
15.308
None
8.61
6.33
6.941
-395.509
7.186
None
None
Cash flow / Revenue
3.963%
None%
4.223%
4.495%
3.204%
-0.067%
4.582%
None%
None%
Sector positioning
Debt ratio
70.112024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE CAMPOURCY (70.11) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.39%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CAMPOURCY (47.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.19 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE CAMPOURCY (7.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 156.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
96.983
90.5
83.442
76.399
78.618
110.711
135.563
140.123
156.451
Interest coverage
16.024
None
12.287
11.17
15.703
49.528
2.55
None
None
Sector positioning
Liquidity ratio
156.452024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+14 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CAMPOURCY (156.45) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.55x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE CAMPOURCY (2.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 52 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 893 days. Excellent situation: suppliers finance 841 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
52 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
893 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CAMPOURCY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
276 446 €
0 €
352 327 €
323 971 €
256 501 €
334 958 €
305 606 €
0 €
0 €
Inventory turnover (days)
51
0
46
40
42
31
42
0
0
Customer payment term (days)
3
0
5
8
8
7
15
408
52
Supplier payment term (days)
51
0
59
59
47
46
68
1622
893
Positioning of PHARMACIE CAMPOURCY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CAMPOURCY is estimated at
955 835 €
(range 665 629€ - 1 429 985€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
665k€955k€1429k€
955 835 €Range: 665 629€ - 1 429 985€
NAF 5 année 2024
Valuation method used
Net Income Multiple
68 466 €
×
14.0x
=955 836 €
Range: 665 629€ - 1 429 985€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CAMPOURCY with other companies in the same sector:
Frequently asked questions about PHARMACIE CAMPOURCY
What is the revenue of PHARMACIE CAMPOURCY ?
The revenue of PHARMACIE CAMPOURCY in 2022 is 2.6 M€.
Is PHARMACIE CAMPOURCY profitable?
Yes, PHARMACIE CAMPOURCY generated a net profit of 68 k€ in 2024.
Where is the headquarters of PHARMACIE CAMPOURCY ?
The headquarters of PHARMACIE CAMPOURCY is located in DREMIL-LAFAGE (31280), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE CAMPOURCY ?
The tax return of PHARMACIE CAMPOURCY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CAMPOURCY operate?
PHARMACIE CAMPOURCY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart